Complex clinical endpoints are present in studies in cancer. Especially in studies on hematopoietic stem-cell transplantation (HSCT), various risks exist after HSCT. Patients can experience acute and chronic graft versus host disease (GVHD) or need to undergo immunosuppressive therapy (IST), a relapse can occur, or patients can die after relapse or without former relapse (nonrelapse mortality, ...

Hospital readmission is a key marker of quality of healthcare; it has been used to investigate variation in quality among patients in a broad range of clinical contexts and has become an important policy measure. Notwithstanding its widespread use, however, readmission remains controversial as a measure of quality. Among the concerns raised, whether and how patient deaths are handled in the ana...

the aim of this study was to assess the predictive effect of the ebmt risk score on the outcomes of allogeneic stem cell transplantation in a relatively homogenous group of acute myelogenous leukemia (aml) patients regarding the occurrence of acute and chronic graft versus host disease (gvhd). this historical cohort study included adult patients (≥ 15 years old) with aml (n=363) who received al...